Why So Few New Cardiovascular Drugs Translate to the Clinics.

about

Properties of porcine adipose-derived stem cells and their applications in preclinical models.Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging Concepts.

P2860

Q39242691-C02F1479-E150-40A4-86CD-259FC502D818 Q49917356-654F022F-C1A8-4A20-8150-5CA09A84F135

P2860

Why So Few New Cardiovascular Drugs Translate to the Clinics.

Item

http://www.wikidata.org/entity/Q41021204

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Why So Few New Cardiovascular Drugs Translate to the Clinics.

@en

type

Item

label

Why So Few New Cardiovascular Drugs Translate to the Clinics.

@en

prefLabel

Why So Few New Cardiovascular Drugs Translate to the Clinics.

@en

P1476

Why So Few New Cardiovascular Drugs Translate to the Clinics.

@en

P2093

Stephen F Vatner

http://www.w3.org/2001/XMLSchema#string

P2860

Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement

Correlation not causation: the relationship between personality traits and political ideologies

Believe it or not: how much can we rely on published data on potential drug targets?

Cardiovascular control mechanisms in the conscious state.

Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.

Myocardial apoptosis in heart disease: does the emperor have clothes?

Interaction of the chemoreflex and the pulmonary inflation reflex in the regulation of coronary circulation in conscious dogs.

Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeys.

Hibernating myocardium.

Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity.

P304

714-717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.116.309512

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27587410

http://www.w3.org/2001/XMLSchema#string

P932

5012301

http://www.w3.org/2001/XMLSchema#string

Why So Few New Cardiovascular Drugs Translate to the Clinics.

about

P2860

P2860

Why So Few New Cardiovascular Drugs Translate to the Clinics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932